Most peptide shots go into belly fat.
To inject a peptide subcutaneously, you wash your hands, wipe the vial top and the skin with alcohol, draw the dose into a fresh U-100 insulin syringe, pinch about an inch of skin, insert the needle at 90 degrees (45 degrees if you are lean), push the plunger, and drop the syringe straight into a sharps container. That is the whole technique, and it is the same one diabetes nurses teach for insulin. Whether the vial says GHK-Cu, BPC-157 or tesamorelin, the shot goes into the fat layer under the skin of the abdomen, thigh or upper arm, never into muscle.
If your hands shake the first time, that is normal. Nearly everyone hesitates over the first shot, and nearly everyone is surprised by how little it hurts.
🔑 Key Takeaways
- Subcutaneous means into the fat under the skin. The belly, outer thigh and upper arm are the sites named in FDA labels and NIH patient guides.
- The shortest needle that works is the right one. Expert guidance names 6 mm syringe needles as first-line.
- Rotation is the step people skip, and it is the one behind most lumps and patchy results.
- One needle, one syringe, one time. Reusing either is how home injections turn into infections.
- GHK-Cu goes in the same way as any other subQ peptide. Its blue colour is not a fault.
Below are the supplies, the nine steps in order, a site-by-site comparison, the GHK-Cu question, and the warning signs that mean a call to your doctor. If you still need to mix the vial, start with how to reconstitute peptides and come back.
What You Need Before Your First Injection
Lay it all out first.
Scrambling for a swab with an uncapped needle in your hand is how mistakes happen. The NIH patient guide lists the same short kit for any subcutaneous shot (MedlinePlus):
- The peptide vial, already reconstituted and inspected. The solution should be clear with no particles.
- A new U-100 insulin syringe for every shot. 0.3 mL, 0.5 mL and 1 mL barrels all read in units, where 100 units equals 1 mL.
- Alcohol pads, one for the vial stopper and one for the skin.
- Clean gauze or a cotton ball for light pressure afterwards.
- A sharps container within arm's reach.
- Your dose in units, worked out before you open anything. The peptide calculator turns mg, mL of water and dose into a syringe mark.
How to Inject Peptides: 9 Steps
Nine steps, about two minutes.
These follow the NIH subcutaneous injection guide (MedlinePlus), the CDC's safe injection rules (CDC) and the injection steps in FDA-approved peptide labels such as tesamorelin (EGRIFTA WR label).
- Wash your hands with soap and running water for at least a minute, then dry them on a clean paper towel.
- Check the vial. Read the label and the date. Use it only if the liquid is clear and free of particles. Cloudy, coloured or speckled solution goes in the bin, not in you.
- Wipe the rubber stopper with an alcohol pad and let it dry.
- Draw the dose. Pull the plunger back to your dose in air, push that air into the vial, turn the vial upside down and draw slightly past your mark. Tap out bubbles and push the plunger back to the exact unit line.
- Pick and clean the site. Choose healthy skin with no redness, scarring or bruising. Wipe from the centre outward in a circle and let it air dry. Wet alcohol stings.
- Pinch about an inch of skin and fat between thumb and finger, lifting it away from the muscle.
- Insert the needle in one quick motion at 90 degrees, or 45 degrees if there is not much fat at that spot.
- Release the pinch and push the plunger steadily until the syringe is empty. Then pull the needle straight out.
- Press, don't rub. Hold gauze on the spot for a few seconds, then put the syringe, needle first, straight into the sharps container. Never recap it.
One needle, one syringe, only one time. That is the CDC's rule, and it also says never to leave a needle sitting in a vial's stopper for repeated draws, because that lets microbes into the fluid (CDC). Insulin syringes are cheap. Infections are not.
Where to Inject Peptides: Sites Compared
Three sites cover almost everyone.
FDA labels for peptide drugs name the same areas the NIH guide does. Zepbound (tirzepatide) is labelled for the abdomen, the thigh, or the back of the upper arm if someone else injects (Zepbound label). Tesamorelin is labelled for the abdomen only, at least 2 inches (5 cm) from the belly button and away from scar tissue, bruises and hard bumps from earlier shots (EGRIFTA WR label).
Some peptides get site-specific advice online, like injecting near an injury. Subcutaneous peptides absorb into the bloodstream from wherever you put them, so the labelled sites above are the safe default. For product-specific notes see where to inject CJC-1295 and ipamorelin and how to inject retatrutide.
Injection Angle, Pinching and Needle Length
Short needles changed the rules.
In 2016, 183 diabetes experts from 54 countries published injection technique recommendations in Mayo Clinic Proceedings. Their headline: the shortest needles, 4 mm on pens and 6 mm on syringes, are safe, effective and less painful, and should be the first choice for every patient group. They also said intramuscular injections should be avoided (Frid et al., 2016). One limitation worth knowing: the workshop was run with needle maker BD, and several authors were BD staff.
What that means at home:
- Use a short insulin syringe needle. 6 mm (often sold as 1/4 inch) or 8 mm (5/16 inch) are the common sizes.
- Pinch with syringe needles. The NIH guide pinches about an inch of skin for every subcutaneous shot (MedlinePlus). It matters most if you are lean.
- Go 90 degrees by default, 45 if you are thin at that spot. The goal is to stay in fat and out of muscle. Our guide to subcutaneous vs intramuscular injection explains why peptides are almost always given subQ.
Site Rotation and Lipohypertrophy
Same spot, every day, is the mistake.
Repeated shots into one patch of skin can build a rubbery lump of fatty tissue called lipohypertrophy. The FITTER authors call it a frequent complication that distorts absorption, say injections should not go into these lumps, and say correct rotation helps prevent them (Frid et al., 2016). The NIH guide puts the minimum spacing at 1 inch between one shot and the next (MedlinePlus), and both the Zepbound and tesamorelin labels tell patients to rotate with every dose.
A simple system: split the belly into four quarters around the navel, use one quarter per week, and move a finger-width within that quarter each shot. If you inject daily, a short log of date, site and units saves you from guessing.
Where to Inject GHK-Cu
GHK-Cu is not special here.
People searching "where to inject GHK-Cu" are usually hoping for a face or scalp spot. Injectable GHK-Cu is given subcutaneously into the same sites as any other peptide, with the belly as the usual first choice. The solution looks blue because of the copper it carries, so a blue tint is expected. Particles, cloudiness or a change from the colour it had when you mixed it are not.
Copper peptide shots are also known for stinging more than most. Injecting slowly and rotating carefully helps. Our GHK-Cu injection guide covers sites, dosing ranges people use and the sting in more detail. If you are still comparing where to buy GHK-Cu, check that the seller publishes a current third-party certificate of analysis for the exact batch, since injecting puts whatever is in the vial straight under your skin.
Mistakes That Cause Bruises, Bumps and Infections
Most problems are technique problems.
- Injecting through wet alcohol. It stings and adds nothing. Let the skin dry.
- Rubbing the site afterwards. Press lightly instead. Rubbing spreads bruising.
- Reusing a syringe "just once." Needles dull after one use and the barrel is no longer sterile (CDC).
- Mixing two peptides in one syringe without checking. The bacteriostatic water label warns that some drugs are incompatible when combined in the same vehicle and says to ask a pharmacist (bacteriostatic water label).
- Skipping rotation. Lumps build quietly, then absorption becomes unpredictable.
- Using a vial that looks off. See how to tell if your peptides have gone bad.
- Throwing loose needles in the trash. The FDA's rule is to put every used sharp into a sharps container immediately, then dispose of the container by your community's rules when it is about three-quarters full (FDA).
When an Injection Reaction Needs a Doctor
Some redness is expected.
Injection site reactions are common even with FDA-approved peptides. In tesamorelin trials, 25% of treated patients had one in the first 26 weeks versus 14% on placebo, mostly redness, itching, pain, irritation and bruising (EGRIFTA WR label). A small pink patch that fades in a day or two fits that picture.
Call a doctor if redness keeps spreading, the spot turns hot or hard, you see pus, or you get a fever. Those are infection signs. Get emergency help for hives, swelling of the lips or face, or trouble breathing. For a wider look at what is normal, see our peptide side effects guide and are peptides safe to inject.
Is Injecting Peptides Legal in 2026?
It depends where the vial came from.
Peptides prescribed as FDA-approved drugs, like tirzepatide or tesamorelin, come with labelled injection instructions. On October 30, 2026, HHS published an enforcement-discretion policy saying it does not intend to take action against state-licensed 503A pharmacies or physicians compounding six peptides (BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500) while FDA works through rulemaking (Federal Register, FR Doc. 2026-22192). That is not FDA approval. The notice itself says compounded drugs are not reviewed by FDA for safety, effectiveness or quality. As of November 2026, a prescription through a compounding pharmacy is the route with the most oversight for those six; see where to buy BPC-157 legally and how to get peptides prescribed.
New to all of this? Our beginner's guide to using peptides walks through dosing, injection and storage in order.
Frequently Asked Questions
Sources
- MedlinePlus (U.S. National Library of Medicine). Giving a subcutaneous injection
- CDC. Injection Safety: Clinical Safety and Safe Injection Practices (incl. USP 797 28-day multi-dose vial rule)
- Frid AH, et al. New Insulin Delivery Recommendations (FITTER). Mayo Clin Proc. 2016;91(9):1231-55. PMID 27594187
- Zepbound (tirzepatide) U.S. Prescribing Information, Eli Lilly, revised 08/2026
- EGRIFTA WR (tesamorelin) Prescribing Information and Instructions for Use, Theratechnologies, revised 03/2025 (DailyMed)
- Bacteriostatic Water for Injection, USP label (Henry Schein), DailyMed
- FDA. Best Way to Get Rid of Used Needles and Other Sharps
- HHS. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. Federal Register, Oct 30, 2026, FR Doc. 2026-22192
This article is for informational and educational purposes only and is not medical advice. Learn injection technique from a licensed clinician or pharmacist, and follow the instructions that come with any prescribed product. Peptides sold outside a prescription have no FDA approval, and their dose, route and frequency should be decided with your doctor based on your health history.
